NL7803C - - Google Patents

Info

Publication number
NL7803C
NL7803C NL7803DA NL7803C NL 7803 C NL7803 C NL 7803C NL 7803D A NL7803D A NL 7803DA NL 7803 C NL7803 C NL 7803C
Authority
NL
Netherlands
Application number
Publication of NL7803C publication Critical patent/NL7803C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13BPRODUCTION OF SUCROSE; APPARATUS SPECIALLY ADAPTED THEREFOR
    • C13B20/00Purification of sugar juices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
NL7803D NL7803C (https=)

Publications (1)

Publication Number Publication Date
NL7803C true NL7803C (https=)

Family

ID=1777585

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7803D NL7803C (https=)

Country Status (1)

Country Link
NL (1) NL7803C (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022109309A1 (en) 2020-11-23 2022-05-27 Vir Biotechnology, Inc. Broadly neutralizing antibodies against influenza neuraminidase

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022109309A1 (en) 2020-11-23 2022-05-27 Vir Biotechnology, Inc. Broadly neutralizing antibodies against influenza neuraminidase

Similar Documents

Publication Publication Date Title
US12030928B2 (en) Anti-influenza B virus neuraminidase antibodies and uses thereof
AU778780B2 (en) Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
US12421301B2 (en) Anti-influenza neuraminidase monoclonal antibodies and uses thereof
CO2023007527A2 (es) Anticuerpos ampliamente neutralizantes contra neuraminidasa de influenza
US10072070B2 (en) Potent anti-influenza A neuraminidase subtype N1 antibody
JP2023551668A5 (https=)
WO2026021428A1 (en) Anti-neuraminidase antibodies and uses thereof
AU2023358546A1 (en) Vaccines and antibodies for the treatment and prevention of microbial infections
NL7803C (https=)